Liminatus Pharma (LIMN) Stock Chart & Stock Price History $1.60 +0.02 (+1.27%) As of 10/8/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsSEC FilingsShort InterestTrendsBuy This Stock Liminatus Pharma Stock Price Performance The Liminatus Pharma (LIMN) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has decreased 34.69%, reflecting recent market activity. As of the latest close, Liminatus Pharma traded at $1.60 with a market cap of $41.62 million and volume of 172,031 shares. Receive LIMN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Liminatus Pharma and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-7.51%1 Month Performance-34.69%3 Month Performance-69.35% LIMN Stock Chart for Thursday, October, 9, 2025 LIMN Chart by TradingView Liminatus Pharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/08/2025$1.58$1.60+1.27%$1.62$1.57172,031 shs$41.62 million10/07/2025$1.73$1.58-8.67%$1.75$1.55495,076 shs$41.10 million10/06/2025$1.73$1.73$1.77$1.64398,846 shs$45.01 million10/03/2025$1.96$1.73-11.73%$1.92$1.601.15 million shs$45.01 million10/02/2025$1.73$1.96+13.29%$2.09$1.881.39 million shs$50.98 million10/01/2025$1.67$1.73+3.59%$2.03$1.671.48 million shs$45.00 million09/30/2025$1.67$1.67$1.69$1.60353,416 shs$43.45 million09/29/2025$1.45$1.67+15.17%$1.71$1.491.01 million shs$43.44 million09/26/2025$1.45$1.45$1.65$1.41796,034 shs$37.71 million09/25/2025$1.43$1.45+1.40%$1.54$1.40534,543 shs$37.71 million Get the Latest News and Ratings for LIMN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Liminatus Pharma and its competitors with MarketBeat's FREE daily newsletter. 09/24/2025$1.68$1.43-14.88%$1.65$1.411.35 million shs$37.20 million09/23/2025$1.43$1.68+17.48%$1.74$1.415.33 million shs$43.70 million09/22/2025$1.26$1.43+13.49%$1.44$1.121.66 million shs$37.19 million09/19/2025$1.29$1.26-2.33%$1.30$1.23623,072 shs$32.77 million09/18/2025$1.59$1.29-18.87%$1.45$1.242.21 million shs$33.56 million09/17/2025$1.79$1.59-11.17%$1.78$1.58624,934 shs$41.36 million09/16/2025$1.85$1.79-3.24%$1.87$1.75344,144 shs$46.56 million09/15/2025$2.00$1.85-7.50%$1.98$1.81482,221 shs$48.13 million09/12/2025$2.08$2.00-3.85%$2.16$1.98650,467 shs$52.03 million09/11/2025$2.03$2.08+2.46%$2.11$1.821.86 million shs$54.10 million09/10/2025$2.45$2.03-17.14%$2.44$2.001.57 million shs$52.80 million09/09/2025$2.31$2.45+6.06%$2.52$2.351.78 million shs$63.73 million09/08/2025$2.67$2.31-13.48%$2.60$2.30485,693 shs$60.08 million Related Companies Seres Therapeutics Stock Chart SELLAS Life Sciences Group Stock Chart Protalix BioTherapeutics Stock Chart Milestone Pharmaceuticals Stock Chart Avalo Therapeutics Stock Chart Protara Therapeutics Stock Chart Citius Oncology Stock Chart Genelux Stock Chart Neoleukin Therapeutics Stock Chart Actuate Therapeutics Stock Chart Receive LIMN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Liminatus Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LIMN) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Liminatus Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Liminatus Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
